GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » COGS-to-Revenue

Oxford Nanopore Technologies (Oxford Nanopore Technologies) COGS-to-Revenue : 0.51 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies COGS-to-Revenue?

Oxford Nanopore Technologies's Cost of Goods Sold for the six months ended in Dec. 2023 was $54.1 Mil. Its Revenue for the six months ended in Dec. 2023 was $105.9 Mil.

Oxford Nanopore Technologies's COGS to Revenue for the six months ended in Dec. 2023 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Oxford Nanopore Technologies's Gross Margin % for the six months ended in Dec. 2023 was 48.93%.


Oxford Nanopore Technologies COGS-to-Revenue Historical Data

The historical data trend for Oxford Nanopore Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies COGS-to-Revenue Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.51 0.59 0.45 0.38 0.47

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.36 0.40 0.42 0.51

Oxford Nanopore Technologies COGS-to-Revenue Calculation

Oxford Nanopore Technologies's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=100.237 / 214.77
=0.47

Oxford Nanopore Technologies's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=54.091 / 105.906
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies  (OTCPK:ONTTF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Oxford Nanopore Technologies's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 54.091 / 105.906
=48.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Oxford Nanopore Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (Oxford Nanopore Technologies) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Headlines

From GuruFocus

ONT Chosen for Comprehensive Human Genome Program

By ACCESSWIRE ACCESSWIRE 05-13-2022

Genomics England Expands Nanopore Use in Cancer

By ACCESSWIRE ACCESSWIRE 04-04-2022

Oxford Nanopore Announces Tech Updates

By ACCESSWIRE ACCESSWIRE 05-20-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

ONT Opens User Conference, Rich Science Programme

By ACCESSWIRE ACCESSWIRE 05-19-2022

Oxford Nanopore Announces Technology Updates

By ACCESSWIRE ACCESSWIRE 12-02-2021

ONT Shows New High-Accuracy, High-Output Chemistry

By ACCESSWIRE ACCESSWIRE 03-30-2022